ARTICLE | Company News
FDA panel backs HyQvia
August 1, 2014 12:41 AM UTC
FDA's Blood Products Advisory Committee voted 15-1 on Thursday that HyQvia from Baxter International Inc. (NYSE:BAX) has a favorable risk-benefit profile. The product is under review as replacement th...